March 15, 2016—Delaware Medicaid has adopted a rule, subject to federal Centers for Medicare & Medicaid Services approval, barring healthcare providers from using 340B-purchased drugs for managed-care and fee-for-service Medicaid beneficiaries.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)